Rheumatology

Resource Center

insights eular 2019

Research Summaries

Research Summary

Shorter-Duration Pegloticase Infusions Safe and Effective in Uncontrolled Gout

10/16/2025

Miranda Manier, BA

In a phase 4 trial, 60-minute pegloticase infusions co-administered with methotrexate demonstrated safety, tolerability, and efficacy comparable to the standard 120-minute duration, with a 67% treatment...

10/16/2025

FDA Alert

FDA Approves Rilzabrutinib Tablets for Chronic Immune Thrombocytopenia

09/10/2025

Kate Young

The FDA recently announced the approval of rilzabrutinib tablets for adults with persistent or chronic immune thrombocytopenia who did not respond to immunoglobulins, anti-D therapy, or corticosteroids. ...

09/10/2025

ACP Internal Medicine 2025 Conference Coverage

ACP Internal Medicine 2025 Conference Coverage

A Primer on Biologics for the Primary Care Physician

04/07/2025

Anthony Calabro, MA

Biologic therapies have revolutionized the treatment of inflammatory arthritis, but their complexity demands practical understanding from clinicians across specialties.

04/07/2025

Research Summary

Illustration of an x-ray of person's body, with the kidneys highlighted.

Research Summary

Study: Obinutuzumab Improves Kidney Outcomes in Lupus Nephritis

12/09/2024

Miranda Manier, BA

Post hoc analyses of the phase 2 NOBILITY trial reveal that adding obinutuzumab to standard lupus nephritis therapy enhances kidney preservation and reduces glucocorticoid reliance.

12/09/2024

Conference Coverage

Conference Coverage

Updates in the Treatment, Management of Osteoporosis and Osteopenia

07/24/2024

Jessica Ganga

Robert Wermers, MD, and Monica Richey, MSN, ANP-bc, provide management updates and guidelines for clinicians who are treating patients with osteoporosis and osteopenia in their session at the Practical...

07/24/2024

May 2026

Current Issue

May 2026